RSCH FPX 7860 Assessment 3: Quantitative Research Plan
- High Quality FPX Sample Assessment
- Step-by-Step Guide to master FPX Assessment
- References (APA Format) for related Assessments
- Connect with Top professors for specific class
- Detailed (FAQs) related to Assessment.
- Express Delivery with in 24 hours.
Assessment Overview:
RSCH FPX 7860 Assessment 3: shows a measurable gap in practice at a 250-bed community sanitarium where drug conciliation is not done at discharge. This leads to drug disagreement, patient confusion, and readmissions that could have been avoided. The document outlines the specific exploration problem, the associated gap, an explanation, supporting evidence, a focused design of interest, compliance with regulations, particular impulses, reflection, and references. A short step-by-step plan for committing the crime and some frequently asked questions follow.
How to Pass RSCH FPX 7860 Assessment 3: Quantitative Research Plan
o Pass
- Define the Transitional Risk: Explicitly link drug list discrepancies to “avoidable patient harm” (ADEs) and the high cost of 30-day readmissions.
- Pinpoint the Gap: Identify the gap as the lack of a Standardized Discharge Workflow—specifically the “diffusion of responsibility” where doctors and pharmacists assume the other has verified the list.
- Advocate for “Pharmacist Verification”: Explain that a pharmacist’s final review is a mechanical safeguard; they are the only ones capable of catching polypharmacy issues before the patient leaves.
- Leverage Gleason & Boockvar Research: Use these studies to prove that structured reconciliation significantly diminishes adverse events, especially for patients with “complex drug rules.”
- Focus on “Teach-Back”: Detail the use of a mandatory Teach-Back Protocol to ensure patients actually understand their new dosages, purposes, and side effects.
- Detail the “Pharmacist-Led Pilot”: Describe the 3-month program on two units, targeting high-risk groups like heart failure, COPD, and diabetes patients.
- Address the “EHR Visibility” Issue: Use your workplace observations to highlight that the lack of a Single-Page Reconciliation Summary in the EHR makes it impossible for clinicians to coordinate.
- Implement 48–72 Hour Follow-Up: Include a post-discharge phone call as part of your intervention to catch misunderstandings once the patient is home and managing their own meds.
- Balance Bias with Resource Realities: In your reflection, acknowledge your preference for “druggist involvement” but admit that staffing and budget realities may require using technicians for data gathering.
- Quantify the ROI: Use Disagreements per Discharge and 30-Day Readmission Rates as your primary KPIs to demonstrate the financial value of the pilot to hospital leadership.
Sample Assessment:
Specific Research Problem
The sanitarium’s discharge process always causes disagreements about the drug list between the outpatient map, the discharge summary, and the drug list that is sent to the primary care provider or pharmacy. These disagreements lead to patient confusion, adverse drug events (ADEs), and a higher risk of readmission within 30 days for cases with complicated drug rules.
Gap in Practice
The gap in practice is that drug conciliation is not done well or consistently at discharge. Some of the basic problems are that there is no standardized conciliation workflow, the places (doctor, nanny, druggist, etc.) are not clear, there is no enforced read-reverse with the case, and drugstore verification is not used enough before discharge.
Why the Specific Gap in Practice Was Chosen
drug reconciliation at transitions of care is a high-impact, evidence-based safety practice. The gap was selected due to its direct correlation with patient harm (ADEs) and costly readmissions, its visibility during attestation/inspection, and its feasibility through modifications in systems, components, and training. People from nursing, pharmacy, and watch collaboration all worked together to fix problems with drug lists in morbidity reviews and discharge checkups.
Research and Effectiveness of Chosen Gap in Practice
Research indicates that structured drug reconciliation diminishes discord and adverse drug events (ADEs) when it incorporates a specified workflow, pharmacist engagement, and patient reassurance (Boockvar et al.; Gleason et al.). Perpetration studies show that there are more goods when conciliation is part of EHR workflows and when druggists do the final verification and teach back with cases. When combined with post-discharge follow-up calls, targeted interventions also lower the rates of adverse events and readmissions after discharge.
RSCH FPX 7860 Assessment 3: Project of Interest
Design and implement a “druggist-led discharge drug reconciliation” for cases with a high risk of drug abuse (5 or more medications or heart failure, COPD, or diabetes). standardized conciliation roster, EHR conciliation template, druggist verification before discharge, mandatory teach-reverse with case/caregiver, and a 48–72 hour post-discharge drugstore follow-up call. Airman for three months on two medical-surgical units with issues of drug disagreement, patient understanding, and 30-day readmissions.
Observations within My Workplace
- Discharge drug lists aren’t always organized in the same way; sometimes, orders for patients to stop or start taking drugs while they are in the hospital aren’t included in the discharge packet.
- It’s not clear who is in charge of conciliation. Croakers think the drugstore looked over it, and druggists think the croaker made the lists better.
- The EHR doesn’t have a simple, one-page summary of all the conciliation cases, which makes it hard to find information across defenses.
- Case education at discharge is rushed, and educate-back doesn’t happen very often.
- These functional compliances make it clear what the workflow and part issues are that keep the gap going.
Personal Biases
I prefer druggist involvement because I value drug safety data and structured processes; this may make me biased against results that benefit drugstores. I need to find a balance between the best possible interventions and the staffing and budget realities of the sanitarium. I also need to think about my options, such as focusing on high-risk cases or reviewing drugs from a distance.
Reflection
Finishing this assessment confirmed that a distinct, well-documented gap (drug reconciliation failures) is connected to obvious system changes (locations, EHR templates, pharmacist verification, educate-back). I learned how to match evidence with feasibility. Putting interventions on high-risk cases has a bigger effect and saves money. The exercise emphasized the importance of assessing both process (conciliation absoluteness) and outcome (disagreement, readmissions).
References (APA 7 Format)
- Gleason, K. M., et al.( 2010). Reconciliation of disagreement in drug histories and admission orders of recently rehabilitated cases. American Journal of Health- System Pharmacy, 67( 13), 1160 – 1166. https://www.ccl.org/articles/leading-effectively-articles/emotional-intelligence-and-leadership-effectiveness/
- Boockvar, K., et al.( 2011). drug conciliation for reducing medicine- distinction adverse events. Journal of General Internal Medicine, 26( 2), 103 – 109.
- World Health Organization.( 2016). drug without detriment — Global patient safety challenge. https://hr.utexas.edu/current/services/problem-solving
- Institute for Healthcare Improvement.( n.d.). drug Reconciliation Change Package.
Rubric Breakdown
| Criterion | Target for Passing |
| Research Problem | Connects drug list discrepancies to ADEs, patient confusion, and 30-day readmission risk. |
| Gap in Practice | Defines the gap as a lack of Standardized Workflows, Role Clarity, and Teach-Back Adherence. |
| Research Support | Integrates Gleason et al. (2010) and WHO “Medication Without Harm” (2016) guidelines. |
| Pilot Design | The “Druggist-Led Pilot” includes an EHR template, mandatory teach-back, and 72-hour follow-up calls. |
| Metric Validity | Tracks Reconciliation Completeness, Teach-Back Scores, and 30-Day Readmissions. |
| Implementation Plan | A 12-week roadmap from “Process Mapping” (Week 2) to “Refining EHR Workflow” (Month 3). |
| Reflection & Bias | Evaluates the tension between “Safety Data/Structured Processes” and “Hospital Staffing Realities.” |
Step-by-Step Guide
- Find the target population and define high-threat discharge cases, such as those with polypharmacy, complicated rules, or recent medication changes.
- Map the current process — A short inspection of the workflow for two weeks to write down where there is disagreement.
- Set up the workflow by making a standard conciliation roster, giving the druggist the job of final verification, and making one EHR conciliation template.
- Teach your staff by giving them detailed sessions for croakers, nursers, and druggists, as well as job aids and scripts for when they need to educate.
- Airman: A three-month airman on two units checks the medications for discharge, teaches the reverse, and makes follow-up calls 48 to 72 hours later.
- Measure and break down—Primary process criteria complete reconciliations, #disagreement per discharge. outgrowth criteria patient understanding (educate-back score), ADEs in the first 30 days, and readmissions in the first 30 days.
- Use airman data to improve places EHR; add it to other units with regular checkups.
Frequently Asked Questions
Q How much extra time will pharmacist verification add to discharge?
For high-threat cases, druggist verification usually adds 10 to 20 minutes to the discharge time; remote verification models can cut down on the time spent on the ward.
Q What if we need enough clinical druggists?
A launch with a targeted airman for high- threat cases, use drugstore technicians for original conciliation gathering, or apply remote/ telepharmacy verification during peak times.
Q How will we be able to accurately measure how well patients understand?
Use a short teach-reverse scoring tool that lists three things: the drug name and purpose, the cure and timing, and what to do if side effects happen. Score at the time of discharge and again during a follow-up call 48 to 72 hours later.
Q Will this cut down on readmissions?
Research indicates that enhanced conciliation and case management diminish drug-related adverse events and can decrease readmission rates, particularly among high-risk populations; however, the original dimension remains crucial.
Q How do we keep the change going?
Put the conciliation template and the required druggist verification into the EHR. Add conciliation criteria to unit dashboards, do regular checkups and give feedback, and add educate-back training to exposure.
Integrity Note
Note: Only use this assessment example for learning and structure purpose. Do not submit as your own work.
We are an independent resource and are not affiliated with Capella University.